Godrej Consumer's CEO handover completes cleanly, easing governance-risk overhang FMCG
Aasif Malbari, GCPL's former CFO, took over as MD & CEO from Aug 12 for a five-year term, with Vishal Kedia named interim CFO. Multiple outlets confirm a defined successor was already in place before Sudhir Sitapati's abrupt exit became public, and no further senior departures or governance/regulatory red flags have surfaced since. This weighs against the open claim that the resignation signaled an undisclosed internal issue, though the claim's Nov 30 resolution window is still running.
Bail denied to TCS executive in Nashik POSH case as litigation deepens at one unit Information Technology
A Nashik court denied bail to TCS executive Ashwini Chainani, finding she allegedly ignored repeated harassment complaints against colleagues; police separately arrested an Assistant General Manager for failing to trigger POSH protocols. Accountability is now being litigated at a senior/panel level, a mild negative for the open claim that this is an isolated, unit-level failure -- though no second TCS facility or new regulator finding has surfaced, so the claim's core framing isn't yet falsified.
Aurobindo subsidiary Eugia Pharma receives US FDA warning letter after OAI classification Pharmaceuticals
Eugia Pharma Specialities, an Aurobindo Pharma subsidiary, received an FDA warning letter following four observations from a February inspection and a May Official-Action-Indicated classification at a Hyderabad-area facility. It's a confirmed compliance flag weighing on AUROPHARMA's pending BUY->HOLD call review, though it's contained to one subsidiary facility and comes alongside a strong Q1 FY27 (revenue +16.3% YoY) and an active Hong Kong investor roadshow.
Mastek's order backlog grows 25% YoY on a $25M Salesforce deal, at odds with today's 8% share drop Information Technology
12-month order backlog rose 25% YoY (13% in constant currency) in Q1 FY27, driven by AI transformation, healthcare, public-sector and financial-services demand, including a five-year, $25M Salesforce Agentforce contract in North America and continued UK ramp-up. The backlog strength argues for the pending HOLD->BUY call flip, but doesn't explain today's -8.05% move -- no company-specific negative catalyst was found in this session's search, so the price action and the fundamentals currently point in different directions.
Aster DM and Advent in talks for a controlling stake in Yatharth Hospitals as hospital consolidation continues Healthcare & Hospitals
Advent International and Aster DM Healthcare are reportedly negotiating for a controlling stake in Yatharth Hospital & Trauma Care Services, part of a broader wave of consolidation across Indian hospital chains amid rising patient volumes and capacity expansion. This is sector-positive M&A activity for two names on this session's watch list, though the talks are not yet a confirmed deal.